Perera M A, Harischandra P A, Wimalaratne O, Damboragama S N
Ceylon Med J. 2000 Jun;45(2):61-4.
To test the feasibility of introducing oral rabies vaccine (vaccinia recombinant rabies glycoprotein) to improve domestic dog immunisation coverage in a selected area.
A prospective field trial.
Panadura, an area relatively isolated by waterways, making it a suitable field laboratory.
A routine parenteral vaccination program was carried out. A house to house survey identified the residual non-vaccinated dogs in the selected area. Oral vaccine was offered to the non-vaccinated domestic dogs.
Of 4322 dogs in the households, 1242 dogs (28.7%) were eligible for oral vaccine. 659 (53%) were considered to have accepted the oral vaccine with release of the vaccine in the oral cavity.
It is feasible to use oral rabies vaccine to enhance immunisation coverage.
测试引入口服狂犬病疫苗（痘苗重组狂犬病糖蛋白）以提高选定地区家犬免疫覆盖率的可行性。
一项前瞻性现场试验。
潘纳杜拉，一个因水路相对隔离的地区，使其成为一个合适的现场实验室。
开展常规的肠胃外疫苗接种计划。逐户调查确定选定地区中仍未接种疫苗的犬只。向未接种疫苗的家犬提供口服疫苗。
在这些家庭的4322只犬中，1242只犬（28.7%）符合口服疫苗接种条件。659只（53%）犬在口腔接种疫苗后被认为已接受口服疫苗。
使用口服狂犬病疫苗提高免疫覆盖率是可行的。
